![]() And the drug Aduhelm was given conditional approval by the Food and Drug Administration in June based primarily on the medication's ability to remove amyloid from the brain.īut many researchers believe amyloid drugs alone can't stop Alzheimer's. The plaques have been the focus of most Alzheimer's drug development in the past 20 years. These approaches are noteworthy because they do not directly attack the sticky amyloid plaques in the brain that are a hallmark of Alzheimer's. Immune cells, toxic protein tangles and brain waves are among the targets of future Alzheimer's treatments, scientists say. ![]() Science Photo Library - ZEPHYR./Getty Images Scientists are working to develop new treatments for Alzheimer's disease by looking beyond amyloid plaques, which have been the focus of most Alzheimer's drug development in the past 20 years. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |